Documents
Application Sponsors
NDA 214408 | ACCORD HLTHCARE INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | SOLUTION;INTRAVENOUS | 100MG/4ML (25MG/ML), | 0 | PEMETREXED | PEMETREXED |
002 | SOLUTION;INTRAVENOUS | 500MG/20ML (25MG/ML) | 0 | PEMETREXED | PEMETREXED |
003 | SOLUTION;INTRAVENOUS | 850MG/34ML (25MG/ML) | 0 | PEMETREXED | PEMETREXED |
004 | SOLUTION;INTRAVENOUS | 1000MG/40ML (25MG/ML). | 0 | PEMETREXED | PEMETREXED |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | TA | 2022-05-17 | STANDARD |
Submissions Property Types
CDER Filings
ACCORD HLTHCARE INC
cder:Array
(
[0] => Array
(
[ApplNo] => 214408
[companyName] => ACCORD HLTHCARE INC
[docInserts] => ["",""]
[products] => [{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"100MG\/4ML (25MG\/ML),","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"500MG\/20ML (25MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"850MG\/34ML (25MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"1000MG\/40ML (25MG\/ML).","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/17\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/214408Orig1s000TA_ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-05-17
)
)